<DOC>
	<DOCNO>NCT00416754</DOCNO>
	<brief_summary>RATIONALE : Genetic counseling use interactive computer program may help woman risk breast cancer make medical decision treatment . PURPOSE : This randomized clinical trial study standard genetic counseling see well work give together without medical decision-making computer program woman risk BRCA1 BRCA2 mutation .</brief_summary>
	<brief_title>Genetic Counseling Women Risk BRCA1 BRCA2 Mutations</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate impact BRCA1/BRCA2 testing among member hereditary breast-ovarian cancer family . - Evaluate long-term impact genetic counseling test psychosocial behavioral outcome . - Evaluate relative impact standard genetic counseling ( SGC ) versus SGC plus interactive decision-aid ( IDA ) medical decision-making . - Evaluate relative impact SGC v SGC + IDA psychological well-being . - Explore mechanism SGC + IDA intervention impact psychosocial behavioral outcome . OUTLINE : This multicenter study . Eligible woman ask participate baseline telephone interview 30 minute invite genetic counseling session 1.5-2 hour include information BRCA1/2 testing . Patients offer BRCA1/2 testing , test result ( i.e. , mutation carrier v noncarrier ) present subsequent in-person individual genetic counseling session 1.5-2 hour . Patients test positive BRCA1 2 mutation randomize 1 2 counseling arm . All patient proceed follow . - Arm I ( standard genetic counseling ) : No counselor-initiated contact schedule . - Arm II ( individualize decision aid ) : Patients ask view interactive computer program design help patient make medical decision base breast cancer risk . Outcome assessment , include quality life assessment , conduct 2 , 6 , 12 month . PROJECTED ACCRUAL : A total 950 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Members hereditary breast/ovarian cancer family ( least 1020 % prior probability BRCA1/2 mutation ) OR firstdegree relative know BRCA1 BRCA2 mutation Prior diagnosis breast cancer allow Must undergo active treatment Patients prior bilateral mastectomy eligible study eligible randomization PATIENT CHARACTERISTICS : Female No psychiatric cognitive disorder would preclude give informed consent PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>